Topiol Sid, Bang-Andersen Benny, Sanchez Connie, Plenge Per, Loland Claus J, Juhl Karsten, Larsen Krestian, Bregnedal Peter, Bøgesø Klaus P
3D-2drug, LLC, P.O. Box 184, Fair Lawn, NJ, USA.
Lundbeck Research, H. Lundbeck A/S, Copenhagen, Denmark.
Bioorg Med Chem Lett. 2017 Feb 1;27(3):470-478. doi: 10.1016/j.bmcl.2016.12.037. Epub 2016 Dec 21.
The recent publication of X-ray structures of SERT includes structures with the potent antidepressant S-Citalopram (S-Cit). Earlier predictions of ligand binding at both a primary (S1) and an allosteric modulator site (S2), were confirmed. We provide herein examples of a series of Citalopram analogs, showing distinct structure-activity relationship (SAR) at both sites that is independent of the SAR at the other site. Analogs with a higher affinity and selectivity than benchmark R-Citalopram (R-Cit) for the S2 versus the S1 site were identified. We deploy structural and computational analyses to explain this SAR and demonstrate the potential utility of the newly emerging X-ray structures within the neurotransmitter:sodium Symporter family for drug design.
血清素转运体(SERT)的X射线结构最近发表,其中包括与强效抗抑郁药S-西酞普兰(S-Cit)结合的结构。先前关于配体在主要位点(S1)和变构调节位点(S2)结合的预测得到了证实。我们在此提供了一系列西酞普兰类似物的实例,显示了这两个位点独特的构效关系(SAR),且彼此独立。我们鉴定出了对S2位点而非S1位点具有比基准R-西酞普兰(R-Cit)更高亲和力和选择性的类似物。我们运用结构和计算分析来解释这种构效关系,并证明神经递质:钠同向转运体家族中新出现的X射线结构在药物设计中的潜在效用。